Skip to main
SRRA

Sierra Oncology (SRRA) Earnings Dates & Reports

Sierra Oncology (SRRA) Most Recent Earnings

Report Date
Period EndingQ1 2022
Est. EPS-$1.03
Actual EPS-$1.33
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Sierra Oncology (SRRA) Earnings per Share (EPS) History

Signup for full access
Browse free

Sierra Oncology (SRRA) Latest Earnings

The value each SRRA share was expected to gain vs. the value each share gained.

Sierra Oncology (SRRA) reported its most recent earnings on for Q1 2022, posting earnings per share (EPS) of -$1.33. This exceeded analysts' expectations of -$1.03 by 29.13%, marking a Miss.

For comparison, Sierra Oncology reported EPS of -$1.46 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Sierra Oncology (SRRA) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2022
-$1.03-$1.33+29.13%
DeckReportListen
Q4 2021
-$1.54-$1.44-6.49%
DeckReportListen
Q3 2021
-$1.51-$1.86+23.18%
DeckReportListen
Q2 2021
-$1.61-$1.41-12.42%
DeckReportListen
Q1 2021
-$1.45-$1.46+0.69%
DeckReportListen
View all

Sierra Oncology (SRRA) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Sierra Oncology’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Sierra Oncology (SRRA) Earnings FAQs

Sierra Oncology (SRRA) last reported earnings on May 6, 2022 for Q1 2022, posting an EPS of -$1.33, which Miss the estimate of -$1.03 by 29.13%.

For Q1 2022, Sierra Oncology (SRRA) reported an EPS of -$1.33, missing analysts' estimate of -$1.03 by 29.13%.

For Q1 2022, Sierra Oncology (SRRA) Miss expectations with an actual EPS of -$1.33 vs. an estimated EPS of -$1.03.

Following the last earnings report on May 6, 2022, Sierra Oncology (SRRA)'s stock price moved — from — to —.

The next Sierra Oncology (SRRA) earnings call is scheduled for May. 6, 2022, where executives will discuss financial results and outlook.

Sierra Oncology (SRRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.